NIH launches phase 1 clinical trial of three mRNA HIV vaccines - ETHealthWorld

The HVTN 302 study will examine whether the following three experimental HIV mRNA vaccines are safe and can induce an immune response on BG505 MD39 mRNA, BG505 MD39.3 gp151 mRNA and BG505 MD39.3 gp151 CD4KO mRNA. Each investigational vaccine candidate is desi…

Bethesda, Maryland : The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a phase 1 clinical trial evaluating three experim… [+3840 chars]

full article...